Sponsor Pipeline

NS Pharma, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 4
1
Phase 2
4
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT04687020 Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical… Duchenne Muscular Dystrophy Active, Not Recruiting
Phase 2
NCT05996003 NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD) Duchenne Muscular Dystrophy Recruiting
NCT07441200 Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH) Pulmonary Arterial Hypertension Not Yet Recruiting
NCT07441278 A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With… Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) Not Yet Recruiting
NCT06046222 Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic… Eosinophilic Granulomatosis With Polyangiitis Active, Not Recruiting
Phase 1/2
NCT06053814 NS-050/NCNP-03 in Boys With DMD (Meteor50) Duchenne Muscular Dystrophy Active, Not Recruiting
Disease Areas
Duchenne Muscular Dystrophy (3) Hypertension (2)
Get alerts when NS Pharma, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free